The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice

Autor:	Pietro Marini, Francesca Comelli, Daniela Parolaro, Vincenzo Di Marzo, Daniele Bolognini, Maria Grazia Cascio, Barbara Costa, Sabatino Maione, Lisa Anne Gauson, Roger G. Pertwee, Ruth A. Ross
Rok vydání:	2010
Předmět:	Pharmacology medicine.medical_specialty Cannabinoid receptor musculoskeletal neural and ocular physiology medicine.medical_treatment food and beverages Inflammation Tetrahydrocannabivarin Blockade chemistry.chemical_compound Endocrinology nervous system chemistry Internal medicine medicine Cannabinoid receptor type 2 lipids (amino acids peptides and proteins) Cannabinoid medicine.symptom Receptor Tetrahydrocannabinol psychological phenomena and processes medicine.drug
Zdroj:	British Journal of Pharmacology. 160:677-687
ISSN:	0007-1188
DOI:	10.1111/j.1476-5381.2010.00756.x
Popis:	Background and purpose: The phytocannabinoid, Δ9-tetrahydrocannabivarin (THCV), can block cannabinoid CB1 receptors. This investigation explored its ability to activate CB2 receptors, there being evidence that combined CB2 activation/CB1 blockade would ameliorate certain disorders.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4dd742e714a65a7e08a49d89d2f7a7e3 https://doi.org/10.1111/j.1476-5381.2010.00756.x Zobrazit plný text záznamu Plný text ve formátu PDF